Category Archives: Generic Drugs

FDA’s Generic Drugs – FDA Tracker Status Update

 A month ago I was able to sit down with FDA's Deputy Commissioner Dr. Joshua Sharfstein to discuss the FDA's new effort at transparency and accountability called FDA Tracker, resulting in a podcast on the subject.  FDA Tracker is a … Continue reading

Posted in FDA Policy, Generic Drugs | Comments Off

FTC Report on Generic Drug Deals

No doubt the latest report from the Federal Trade Commission (FTC) Bureau of Competition is going to set the hair of several congresspeople on fire and will perhaps result in a hearing on the matter.  The subject of the report … Continue reading

Posted in Generic Drugs, Industry Image | 1 Comment

The Critical Path of the Critical Path

Yesterday the FDA issued a news release that was entitled the "Critical Path Opportunities for Generic Drugs" that raises more than a few interesting points. First, it has been a long time since we’ve heard much about the FDA’s Critical … Continue reading

Posted in Generic Drugs | 1 Comment

Global Warming for Generics

Lately the environment for generic drugs has grown much warmer. Consider, last week the FDA/CDER proposed a speedier process for considering approval of generics. Walmart, one of the biggest retail chains in the country, announced it would sell many generics … Continue reading

Posted in Generic Drugs | 2 Comments

The Mr. Bills Show

TORONTO, ONTARIO – On the first full day of the XVI International AIDS Conference, a panel was held of two distinguished men named Bill – one was Bill Gates and the other was Bill Clinton.   For an hour and a … Continue reading

Posted in Current Affairs, FDA Policy, Generic Drugs | Comments Off